Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

FOOTTRAK

K-Number: K890075 · 1989-02-03

Decision Date1989-02-03
Product CodeLXJ
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

FOOTTRAK is the device name listed in this FDA 510(k) record. The listed applicant is Motion Analysis Corp.. It received FDA 510(k) clearance on 1989-02-03 under 510(k) number K890075. The device is classified under product code LXJ. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the FOOTTRAK?

FOOTTRAK is a medical device that received FDA 510(k) clearance on 1989-02-03. The listed applicant is Motion Analysis Corp.. The 510(k) number is K890075.

When did FOOTTRAK receive FDA 510(k) clearance?

FOOTTRAK received FDA 510(k) clearance on 1989-02-03, under 510(k) number K890075.

Who is the listed applicant for FOOTTRAK?

The FDA 510(k) record lists Motion Analysis Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for FOOTTRAK?

The FDA product code for FOOTTRAK is LXJ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Motion Analysis Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LXJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑